Key facts
- This page summarizes Aquilo Capital Management, LLC's Form 4 filing for Spero Therapeutics, Inc. (SPRO).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 26 Sep 2022, 15:32.
Aquilo Capital Management, LLC - 22 Sep 2022 Form 4 Insider Report for Spero Therapeutics, Inc. (SPRO)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- SPRO
- Reported as of
- 22 Sep 2022
- Net transaction value
- -$4,279,612
- SEC form
- 4
- Accepted by SEC
- 26 Sep 2022, 15:32:06 UTC
- Prior SEC filing
- 28 Apr 2022
- Source filing
- View source filing
- Reporting owner signature
- Aquilo Capital Management, LLC By: Marc Schneidman, its Managing Member, /s/ Marc Schneidman
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Aquilo Capital Management, LLC filed Form 4 for Spero Therapeutics, Inc. (SPRO) on 26 Sep 2022.
Change
- Previous filing in this sequence was filed on 28 Apr 2022.
- Current net transaction value: -$4,279,612.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SPRO
transaction
Common Stock, $0.001 par value
Sale
- Transaction value
- $3,005,303
- Shares
- -1,335,512
- Change %
- -25%
- Price
- $2.25
- Shares after
- 3,985,719
- Date
- 22 Sep 2022
- Ownership
- See Footnotes
- Footnotes
- F1, F2
SPRO
transaction
Common Stock, $0.001 par value
Sale
- Transaction value
- $1,274,309
- Shares
- -566,284
- Change %
- -14%
- Price
- $2.25
- Shares after
- 3,419,435
- Date
- 22 Sep 2022
- Ownership
- See Footnotes
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Aquilo Capital Management, LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 3 footnotes
Footnote F1
The reporting persons are Aquilo Capital, L.P. (the "Fund"), Aquilo Capital Management, LLC ("Aquilo") and Marc R. Schneidman. Aquilo is the general partner and investment adviser of the Fund and other funds managed by Aquilo that hold securities directly for the benefit of their investors. Aquilo may be deemed to beneficially own such securities indirectly as the investment adviser and general partner of the Fund and affiliated funds, and Mr. Schneidman may be deemed to beneficially own them indirectly as the control person of Aquilo. Each of, Aquilo, the Fund and Mr. Schneidman disclaims beneficial ownership of such securities except to the extent of his or its pecuniary interest therein.
Footnote F2
Aquilo Capital, LP owns 2,176,470 of the 3,985,719 shares deemed to be beneficially owned by Aquilo Capital Management, LLC. Aquilo Capital, LP sold 1,335,512 shares in this transaction on 09/22/2022.
Footnote F3
Aquilo Capital, LP owns only 2,176,470 of the 3,419,435 shares deemed to be beneficially owned by Aquilo Capital Management, LLC. Aquilo Capital, LP did not sell any of the 566,284 shares sold in this transaction on 09/22/2022.